(Q52124518)

22 April 2018

title

Psychiatric and neuropsychological response to propranolol in Graves' disease (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

2 January 2023

1 reference

neuropsychological tests

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370265

2 January 2023

author name string

P. T. Trzepacz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370265

2 January 2023

M. McCue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370265

2 January 2023

I. Klein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370265

2 January 2023

J. Greenhouse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370265

2 January 2023

G. S. Levey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3370265

2 January 2023

language of work or name

English

0 references

publication date

1 April 1988

1 reference

22 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0006322388900510?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

https://api.elsevier.com/content/article/PII:0006322388900510?httpAccept=text/plain

2 January 2023

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

2 January 2023

published in

Biological Psychiatry

1 reference

22 April 2018

volume

23

1 reference

22 April 2018

issue

7

1 reference

22 April 2018

page(s)

678-688

1 reference

22 April 2018

Attention disturbance in Graves' disease

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Development of β-adrenergic receptor subsensitivity by antidepressants

2 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Urinary excretion of free catecholamines in Graves' disease

2 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

The Influence of Hyperthyroidism and Hypothyroidism on α and β-Adrenergic Receptor Systems and Adrenergic Responsiveness*

2 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

2 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Central Nervous Actions of β-Adrenoreceptor Antagonists

2 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Catecholamines Metabolism in Thyroid Diseases. I. Epinephrine Secretion Rate in Hyperthyroidism and Hypothyroidism

2 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism

2 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Diagnosis of organic anxiety disorders

2 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A diagnostic interview: the schedule for affective disorders and schizophrenia

2 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Organic affective disorder and underlying thyrotoxicosis

2 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Triiodothyronine-induced Thyrotoxicosis Increases Mononuclear Leukocyte β-Adrenergic Receptor Density in Man

2 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Effect of Acute ß-Adrenergic Blockade on Lactate-Induced Panic

2 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A rating scale for depression

2 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

The effect of beta adrenergic blocking drugs on speakers' performance and memory.

2 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

2 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Appearance of manic psychosis following rapid normalization of thyroid status

2 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Hyperthyroidism and panic attacks.

2 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Propranolol in chronic anxiety disorders. A controlled study

2 January 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

New perspectives on thyroid hormone, catecholamines, and the heart

2 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Symptom rating scale for assessing hyperthyroidism

2 January 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

An objective measure of physical activity for epidemiologic research

2 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study

2 January 2023

33

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Modulating effects of posttraining epinephrine on memory: involvement of the amygdala noradrenergic system

2 January 2023

34

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Emotional disturbance and cognitive deficits in hyperthyroidism

2 January 2023

35

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Hypothyroidism Elicits Electrophysiological Noradrenergic Subsensitivity in Rat Cerebellum

2 January 2023

36

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Preserving the presence of the past. Hormonal influences on memory storage.

2 January 2023

37

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Beta-blocking drugs and anxiety

2 January 2023

38

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Thyroid Hormone Action at the Cellular Level

2 January 2023

39

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Modification of β-adrenergic receptor binding in rat brain following thyroxine administration

2 January 2023

41

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Propranolol and depression

2 January 2023

42

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Treatment of Hypertension with Propranolol

2 January 2023

44

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Effects of thyroid state on brain development: β-Adrenergic receptors and 5′-nucleotidase activity

2 January 2023

48

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: Implications for the therapy of depression

2 January 2023

50

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Propranolol in the treatment of anxiety

2 January 2023

51

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists

2 January 2023

52

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A psychiatric and neuropsychological study of patients with untreated Graves' disease

2 January 2023

53

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A Standardized Memory Scale for Clinical Use

2 January 2023

54

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness

2 January 2023

56

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement.

2 January 2023

57

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Research diagnostic criteria and DSM-III: an annotated comparison

2 January 2023

58

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Motor activity and affective illness. The relationship of amplitude and temporal distribution to changes in affective state

2 January 2023

60

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Organic affective disorder associated with thyrotoxicosis

2 January 2023

61

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

A rating scale for mania: reliability, validity and sensitivity

2 January 2023

62

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

Propranolol in hypertension: a study of long-term therapy, 1964-1970

2 January 2023

63

1 reference

https://api.crossref.org/works/10.1016/0006-3223(88)90051-0

2 January 2023

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018